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a b s t r a c t
Introduction: MRSA population dynamics is undergoing significant changes, and for this reason it is
important to know which clones are circulating in our nosocomial environment.
Materials and methods: A total of 118 MRSA isolates were collected from clinical samples from patients
with previous hospital or healthcare contact (named as hospital-onset MRSA (HO-MRSA)) during a one
year period. Susceptibility testing was performed by disk diffusion and microdilution. The presence of
resistance genes and virulence factors were tested by PCR. All isolates were typed by SCCmec, spa and
agr typing. PFGE and MLST were applied to a selection of them.
Results: Eighty-three HO-MRSA isolates (70.3%) were resistant to any antibiotic included in the
macrolide–lincosamide–streptogramin B group. Among these isolates, the M phenotype was the most
frequent (73.5%).OnehundredandsevenofHO-MRSA isolates (90.7%) showedaminoglycoside resistance.
The combination aac(6′)-Ie-aph(2′′)-Ia + ant(4′)-Ia genes was the most frequent (22.4%). Tetracycline
resistance rates in HO-MRSA isolates were low (3.4%), although a high level of mupirocin resistance
was observed (25.4%). Most of the HO-MRSA isolates (approximately 90%) showed SCCmec type IVc and
agr type II. Fifteen unrelated pulsotypes were identified. CC5 was the most prevalent (88.1%), followed
by CC8 (5.9%), CC22 (2.5%), CC398 (2.5%) and CC1 (0.8%).
Conclusion: CC5/ST125/t067 lineage was the most frequent. This lineage was related to aminoglycoside
resistance, and to a lesser extent, with macrolide resistance. The presence of international clones as
EMRSA-15 (CC22/ST22), European clones as CC5/ST228, community clones related to CC1 or CC8 and
livestock associated clones, as CC398, were observed in a low percentage.
© 2015 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Enfermedades
Infecciosas y Microbiología Clínica.
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Líneas clonales
Genes de resistencia
Tipado molecular
Resistencia a antibióticos, factores de virulencia y líneas clonales de
Staphylococcus aureus resistente a la meticilina de origen hospitalario en un
hospital de Zaragoza
r e s u m e n
Introducción: Las dinámicas poblacionales de SARM están experimentando cambios significativos en
los últimos tiempos. Por ello es importante conocer qué líneas clonales circulan en nuestro ambiente
hospitalario.
Materiales y métodos: Durante un an˜o, se seleccionaron 118 SARM de muestras clínicas de pacientes
con contacto previo con el ambiente hospitalario (SARM de origen hospitalario [SARM-OH]). Las pruebas
de sensibilidad se realizaron mediante difusión con discos y microdilución. La presencia de genes de
resistencia y factores de virulencia fueron estudiados mediante PCR. Se estableció el tipo de SCC-mec, spa
y agr en todos los aislados, y en una selección se estudió su relación genética por PFGE y MLST.
Resultados: Ochenta y tres SARM-OH (70,3%) fueron resistentes a al menos un antibiótico del grupo de
los macrólidos-lincosamidas-estreptograminas B. Entre estos, el fenotipo M fue el más frecuente (73,5%).
Ciento siete aislamientos (90,7%) mostraron resistencia a aminoglucósidos. La combinación aac(6′)-Ie-
aph(2′′)-Ia + ant(4′)-Ia fue la más frecuente (22,4%). Las tasas de resistencia a tetraciclinas detectadas
fueron bajas (3,4%). Se observó un 25,4% de resistencia de alto nivel a mupirocina. Aproximadamente un
90% de SARM-OH mostraron SCC-mec tipo IVc y agr tipo II. Se identificaron 15 pulsotipos no relacionados.
El CC5 fue el más prevalente (88,1%) seguido de CC8 (5,9%), CC22 (2,5%), CC398 (2,5%) y CC1 (0,8%).
Conclusión: La línea clonal CC5/ST125/t067 fue la más habitual. Esta línea se relacionó con resistencia
a aminoglucósidos, y, en menor medida, con macrólidos. La presencia de clones internacionales como
EMRSA-15 (CC22/ST22), clones europeos como CC5/ST228, clones comunitarios relacionados con CC1 o
CC8 y clones asociados al ganado, como el CC398, se observaron en un bajo porcentaje.
© 2015 Publicado por Elsevier España, S.L.U. en nombre de Sociedad Española de Enfermedades
Infecciosas y Microbiología Clínica.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a lead-
ing cause of human bacterial infections worldwide.1 Currently,
MRSA is now endemic inmany hospitals and healthcare facilities in
industrializedcountries.2 TheprevalenceofMRSAamongEuropean
countries varies considerably being significantly lower in northern
countries (approximately 1 or 2%) than in other European countries
(up to 45%).3
In recent years, polyclonal emergence of new clones hasQ2
been described. Pandemic spread of different hospital-associated
MRSA (HA-MRSA) clones, as ST239/SCCmecIII-IV, EMRSA-16 or
ST36/SCCmecII (CC30) and ST125/SCCmecIV (CC5) and community-
associated MRSA (CA-MRSA) clones, as ST1/SCCmecIV (CC1), USA
300 or ST8/SCCmecIV (CC8), ST30/SCCmecIV (CC30) has been
observed.4–6 To date, livestock-associated MRSA (LA-MRSA) clones
has not been frequently identified in hospitals or nursing homes in
Europe, although the spread seems to be dependent on the region
and the intensity of pig farming.7
In Spain in early twenties, the dominant clone was Iberian
clone (ST247/SCCmecI) but over the years this clone has reduced
its presence.8 Currently, the most widespread HA-MRSA clone is
ST125/SCCmecIV/t067 which is an allelic variant of ST5 pediatric
clone.9
MRSA population dynamics is undergoing significant changes
due to demographic variations such as immigration and the devel-
opment of sophisticated and complex health systems (i.e. care of
patients with severe underlying diseases and invasive devices in
day hospitals, residency in a long-term care facility. . .).4 For this
reason it is more difficult to establish the epidemiology of MRSA
infections. The aim of the study was to analyze the molecular epi-
demiology, clonal lineages, resistance mechanisms and virulence
traits of hospital and healthcare associated MRSA clones to under-
stand the epidemiology of these infections.
Materials and methods
Setting
The study was performed in the University Teaching Hospital
“Lozano Blesa” (Zaragoza, Spain), with 803 beds attending a popu-
lation of 286,774 inhabitants with 29,506 annual admissions. The
study was conducted between July 2009 and July 2010.
Bacterial isolates and patient information
A total of 118 MRSA isolates were collected in our institution
from clinical samples belonged to patients with previous hospital
or healthcare contact (named as hospital or healthcare onsetMRSA,
HO-MRSA). HO-MRSA was defined as an isolate cultured from a
clinical specimens obtained ≥72h after patient’s hospital admis-
sion or whose sources of isolation were associated with one of the
following hospital or healthcare risk factors: history of previous
hospitalization, surgeries or dialysis, residency in a long-term care
facility, the presence ofmedical devices or previousMRSA infection
or colonization.
One isolate per patient was included. For each patient the fol-
lowing data were collected: gender, age, nationality, source of the
culture sample and underlying disease.
Identification and antimicrobial susceptibility testing
The identification was performed using WIDER I System
(Francisco Soria-Melguizo, Madrid, Spain). Susceptibility testing
to cefoxitin, erythromycin, azithromycin, spiramycin, clindamycin,
pristinamycin, chloramphenicol, tetracycline, minocycline, strep-
tomycin, gentamicin, tobramycin, amikacin, kanamycin and
netilmicin (Mast Diagnostics, Bootle, UK and Bio-Rad, Marnes La
Coquette, France) was performed by disk diffusion and interpreted
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according to CLSI guidelines10 and the Société Franc¸aise de
Microbiologie breakpoints (http://www.sfm-microbiologie.org).
Mupirocin susceptibility testing was confirmed by E-test strip
method.
Resistance genotypes and virulence factors
The presence of mecA, aac(6′)-Ie-aph(2′′)-Ia, aph(3′)-IIIa, ant(4′)-
Ia, erm(A), erm(B), erm(C), msr(A), vga(A), vga(C), lnu(A), tet(K),
tet(M), tet(L) and mupA resistance genes was tested by PCR as pre-
viously described.11,12 The presence of virulence genes encoding
the Panton Valentine leukocidin (PVL) (lukF/lukS-PV), TSST-1 (tst),
Exfoliative Toxin A (ETA) (eta), B (ETB) (etb) was investigated by
PCR.12 Positive and negative controls were included in all PCRs.
Molecular typing of isolates
All MRSA isolates were typed (SCCmec, spa and agr typing) as
previously described.12
Pulsed field gel electrophoresis (PFGE) using SmaI and EagI
restriction enzymes (New England Biolabs, Hertfordshire, United
Kingdom) was performed in the isolates with different spa types,
isolates with the same spa type but with different antibiotic
resistance profile and mupirocin or tetracycline resistance.13 EagI
restriction enzyme was used in tetracycline resistant isolates
because presumably could be related to the CC398 which are
non-typeable by SmaI. Profiles were analyzed with BioNumerics
fingerprinting software (Applied Maths, Kortrijk, Belgium). Den-
drograms were generated by the unweighted pair-group method
using arithmetic averages, based on the Dice similarity coefficient
with a 1.0% band position tolerance.14 PFGE patternswere assigned
into pulsotypes (named with capital letters) and subtypes (named
with numbers). Different pulsotypes were considered if the sim-
ilarity coefficient was <80%. Different subtypes were considered
when the similarity coefficient oscillates in the 80–95% interval.
Sixteen selected MRSA isolates (isolates represented of each
PFGE type and the isolate with the new spa type (t10034)) were
characterized by MLST amplifying fragments of arcC, aroE, glpF,
gmk, pta, tpi, and yqiL housekeeping loci.15 All amplicons were
sequenced and compared with the MLST database in order to know
the sequence type (ST). The assignment of Clonal Complexes (CC)
was achieved according to the ST determined (in 16 isolates). In
those cases in which STs were not determined, CCs of the iso-
lates was presumably assigned according to the spa type (in the
remaining 102 isolates).
Results
Overview and epidemiological data
A total of 118 HO-MRSA isolates were collected from clini-
cal samples during one year. These isolates belonged to 72 male
(61.1%) and 46 female (38.9%). The median age and standard devi-
ation of these patients was 75.27±15.06 years old (range 1–96).
These isolatesweremostly recovered fromskin lesions andwounds
(60%). The remaining isolates were obtained from lower respira-
tory tract samples (20%), urine samples (8%), blood (5%), abscesses
(4%) and upper respiratory samples (2%). These isolates were
more frequently found in primary care (20.3%), internal medicine
(18.6%), vascular surgery (14.4%), emergency department (8.5%),
pulmonology (6.7%) and intensive care unit (5.9%).
The predominant risks factors during the year prior to MRSA
isolationwerehospitalization (71.9%), residency ina long-termcare
facility (38%), surgery (38%), medical devices (38%), dialysis (2.5%)
or previous MRSA infection or colonization (2.5%).
Most common underlying diseases (often combined) were
cardiovascular (80.5%), diabetes (25.3%), and neoplastic dis-
ease (27.1%). Other underlying diseases were found in 9.3% of
the patients.
Susceptibility testing, detection of antimicrobial resistance genes
and virulence factors
All isolates showed resistance to betalactam antibiotics tested
(cefoxitin, oxacillin, and amoxicillin–clavulanate) and mecA gene
was amplified in all of them. Table 1 shows the characteristics
of 118 HO-MRSA isolates including their phenotype and genotype
resistance.
Eighty-three HO-MRSA isolates (70.3%) were resistant to any
antibiotic included in the macrolide–lincosamide–streptogramin
B (MLSB) group. The rates of erythromycin and azithromycin
resistance were high (68.6% in both cases). Among erythromycin
resistant isolates, the M phenotype was detected in 73.5% of
them encoded by msr(A) (71.1%) and msr(A) + erm(B) genes
(2.4%). Constitutive resistance (cMLSB phenotype) was observed
in 16.9% of erythromycin resistant isolates encoded by erm(C)
gene (7.2%), erm(A) gene (2.4%), erm(A) + erm(B) genes (3.6%) and
msr(A) + erm(C) genes in 3.6% of the isolates. Inducible resistance
(iMLSB phenotype) encoded by erm(C) was detected in 8.4% of
resistant isolates. Finally, the L phenotype was observed in 1.2%
of erythromycin resistant isolates encoded by lnu(A) gene.
One hundred and seven of HO-MRSA isolates (90.7%) showed
resistance to any antibiotics included in the aminoglycoside family,
mainly kanamycin (89%), tobramycin (72.9%) and amikacin (53.4%).
ant(4′)-Ia gene was the most frequently detected (49.5%), followed
by aph(3′)-IIIa (11.2%) and aac(6′)-Ie-aph(2′′)-Ia genes (3.7%). One-
third of isolates (33.6%) showed combinations of several resistance
genes. The combination aac(6′)-Ie-aph(2′′)-Ia + ant(4′)-Ia geneswas
the most frequent (22.4%). In two isolates, which showed only
streptomycin resistance, we could not determine the resistance
gene profile.
Tetracycline resistance rates in HO-MRSA isolates were low
(3.4%). Four isolates showed tetracycline resistance encoded by
tet(K) and tet(M) + tet(K) genes. One isolate exhibited tetracycline
and minocycline resistance encoded by tet(M).
Mupirocin MICs ≥256mg/L were found in 30 isolates (25.4%)
(the rest of themshowedMICs <8mg/L).HighmupirocinMICswere
confirmed by E-test strip method showing high level mupirocin
resistance (MIC> 512mg/L). This resistance was encoded by mupA
gene.
The genes encoding the PVL were detected in 3 of our 118 HO-
MRSA isolates (2.5%). Only one isolate with tst gene was detected.
This isolate, obtained from a respiratory specimen (sputum) from
HIV patient, carry erm(C) and ant(4′)-Ia genes and was included in
ST5/spat9298/SCCmecI/agrII profile. Genes encoding A and B exfo-
liatins were not detected in any isolate.
Molecular typing of isolates
Most of the HO-MRSA isolates (90%) showed SCCmec type IVc.
Other SCCmec found were: SCCmec type I (4.2%), SCCmec type IVh
(2.5%), SCCmec type V (2.5%) and SCCmec type IVa (0.8%) (Table 1).
Highly diverse spa types were identified among HO-MRSA.
The most frequently detected was spa type t067 (61%) followed
by t2220 (7.6%), t2226 (6.7%), t002 (5.1%), t008 (4.2%), t041
(4.2%), t011 (2.5%) and t032 (1.7%). Sporadically spa types t068,
t127, t1302, t190, t306, t4978 and t9298 were detected. A new
spa type, spa t10034, was identified in this study which was
subsequently included in Ridom StaphType® software. This new
spa type belongs to ST5.
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Table 1
Antimicrobial resistance, virulence genes and genetic lineages of 118 HO-MRSA isolates.
CC ST (n) number
of isolates
spa type (n)
number of
isolates
SCCmec agr PVL/TSST PGFE profile (n)
number of
isolates
Resistance profile* (n) number of
isolates
Resistance genes
5
ND
067 (72) IVc II –
pA3 (1) ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND pA4 (1) ERY, AZM, SPI, CLI, TOB, KAN erm(C), ant(4′)-Ia
ND pA5 (2) ERY, AZM, SPI, CLI, TOB, AMI, KAN erm(C), ant(4′)-Ia
ND TOB, KAN, CLO ant(4′)-Ia
ND pA7 (2) ERY, AZM, GEN, TOB, AMI, KAN msr(A), aac(6′)-Ie-aph(2′′)
ND TOB, AMI, KAN ant(4′)-Ia
ND pA8 (1) ERY, AZM, SPI, CLI, TOB, AMI, KAN erm(C), ant(4′)-Ia
ND pA9 (2) ERY, AZM, KAN msr(A), ant(4′)-Ia
ND GEN, TOB, AMI, KAN, MUP aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND pA10 (1) TOB, AMI, KAN ant(4′)-Ia
ND pA11 (1) ERY, AZM, SPI, CLI, TOB, AMI, KAN, STR,
MUP
erm(C), ant(4′)-Ia, mupA
ND
pA12 (2)
ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND ERY, AZM, SPI, CLI, GEN, TOB, AMI,
KAN, MUP
msr(A), erm(C), aac(6′)-Ie-aph(2′′), ant(4′)-Ia,
aph(3′)-IIIa, mupA
ND
pA13 (6)
ERY, AZM, GEN, TOB, AMI, KAN, STR,
MUP
msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND ERY, AZM, SPI, CLI, GEN, TOB, AMI,
KAN, MUP
msr(A), erm(C), aac(6′)-Ie-aph(2′′), ant(4′)-Ia,
aph(3′)-IIIa, mupA
ND ERY, AZM, GEN, TOB, AMI, KAN, MUP
(2)
msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND ERY, AZM, GEN, TOB, AMI, KAN, NET,
MUP
msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND GEN, TOB, AMI, KAN, STR, NET, MUP aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND
pA14 (2)
ERY, AZM, TOB, AMI, KAN, STR msr(A), ant(4′)-Ia, aph(3′)-IIIa
ND ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND pA17 (1) TOB, KAN ant(4′)-Ia
ND pA18 (1) – –
ND
pA19 (2)
GEN, TOB, AMI, KAN, MUP aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND ERY, AZM, GEN, TOB, AMI, KAN, STR,
MUP
msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, aph(3′)-IIIa, mupA
ND pA20 (1) ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, aph(3′)-IIIa, mupA
ND pA21 (1) ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND
pA22 (3)
ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, aph(3′)-IIIa, mupA
ND ERY, AZM, GEN, TOB, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), mupA
125 pB1 (1) ERY, AZM, KAN, STR, CLO msr(A), aph(3′)-IIIa
ND
pC3 (2)
ERY, AZM, TOB, AMI, KAN, STR, CLO msr(A), ant(4′)-Ia
ND ERY, AZM, TOB, KAN msr(A), ant(4′)-Ia
ND
pC4 (3)
ERY, AZM, KAN (2) msr(A), aph(3′)-IIIa
ND ERY, AZM, TOB, AMI, KAN msr(A), erm(B), ant(4′)-Ia
ND pC5 (1) GEN, TOB, KAN, MUP aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND pC6 (1) ERY, AZM, TOB, AMI, KAN msr(A), ant(4′)-Ia
ND pC7 (1) ERY, AZM, TOB, AMI, KAN, CLO msr(A), ant(4′)-Ia
125 pD1 (1) ERY, AZM, SPI, CLI, GEN, TOB, AMI,
KAN, MUP
msr(A), erm(C), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
125 pE1 (1) ERY, SPI, STR, CLO erm(C)
ND
ND (31)
ERY, AZM, GEN, TOB, AMI, KAN erm(C), aac(6′)-Ie-aph(2′′), ant(4′)-Ia
ND ERY, AZM, GEN, TOB, AMI, KAN, MUP
(2)
msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, aph(3′)-IIIa, mupA
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Table 1 (Continued)
CC ST (n) number
of isolates
spa type (n)
number of
isolates
SCCmec agr PVL/TSST PGFE profile (n)
number of
isolates
Resistance profile* (n) number of
isolates
Resistance genes
ND ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), erm(B), aac(6′)-Ie-aph(2′′), ant(4′)-Ia,
aph(3′)-IIIa, mupA
ND ERY, AZM, KAN (2) msr(A), aph(3′)-IIIa
ND ERY, AZM, KAN (2) msr(A), ant(4′)-Ia
ND ERY, AZM, SPI, CLI, TOB, KAN erm(C), ant(4′)-Ia
ND ERY, AZM, TOB, AMI, KAN (12) msr(A), ant(4′)-Ia
ND ERY, AZM, TOB, AMI, KAN msr(A), ant(4′)-Ia, aph(3′)-IIIa
ND ERY, AZM, TOB, AMI, KAN, CLO msr(A), ant(4′)-Ia
ND ERY, AZM, TOB, AMI, KAN, STR msr(A), ant(4′)-Ia
ND ERY, AZM, TOB, KAN (2) msr(A), ant(4′)-Ia
ND TOB, AMI, KAN (4) ant(4′)-Ia
ND
2220 (9) IVc II –
pA16 (1) ERY, AZM, KAN, MUP msr(A), aph(3′)-IIIa, mupA
125
pC1 (2)
ERY, AZM, KAN, STR msr(A), ant(4′)-Ia
ND ERY, AZM, AMI, KAN msr(A), ant(4′)-Ia
ND pC5 (1) ERY, AZM, KAN msr(A), aph(3′)-IIIa
ND pC8 (1) ERY, AZM, KAN msr(A) aph(3′)-IIIa
ND ND (4) ERY, AZM, KAN msr(A), aph(3′)-IIIa
ND
2226 (8) IVc II –
pA4 (1) TOB, AMI, KAN, STR ant(4′)-Ia
ND pA5 (1) GEN, TOB, AMI, KAN, MUP aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND pA6 (2) GEN, TOB, AMI, KAN, MUP aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND pA14 (1) ERY, AZM, GEN, TOB, AMI, KAN, MUP msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, mupA
ND pA15 (1) TOB, KAN ant(4′)-Ia
ND ND (2) TOB, KAN ant(4′)-Ia
125 4978 IVc II – pG1 (1) ERY, AZM, KAN, CLO msr(A), aph(3′)-IIIa
146 (1)
002 (6) IVc II –
pA1 (2) ERY, AZM, TOB, AMI, KAN erm(C), ant(4′)-Ia
ND pA17 (1) – –
ND pA18 (1) – –
ND
ND (2)
– –
ND TOB, AMI, KAN, STR ant(4′)-Ia
228
041 (5) I II
–
pF1 (3)
ERY, AZM, SPI, CLI, GEN, TOB, KAN, STR erm(A), erm(B), aac(6′)-Ie-aph(2′′)
ND – ERY, AZM, SPI, CLI, GEN, TOB, KAN, STR erm(A), aac(6′)-Ie-aph(2′′), aph(3′)-IIIa
ND – ERY, AZM, SPI, CLI, GEN, TOB, KAN, STR erm(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia
ND – pF2 (1) ERY, AZM, SPI, CLI, GEN, TOB, KAN, STR erm(A), erm(B), aac(6′)-Ie-aph(2′′), aph(3′)-IIIa
ND IVc – pF1 (1) ERY, AZM, SPI, CLI, GEN, TOB, KAN, STR erm(A), erm(B), aac(6′)-Ie-aph(2′′), aph(3′)-IIIa
ND 306 IVc
II
– pA2 (1) TOB, KAN ant(4′)-Ia
5 9298 I TSST+ pH1 (1) ERY, AZM, TOB, KAN erm(C), ant(4′)-Ia
5 10,034 IVc – pC2 (1) ERY, AZM, GEN, TOB, AMI, KAN msr(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia
8
8 (1)
008 (5) IVc I
PVL+ pI1 (2) – –
8 – pK1 (1) TOB, AMI, KAN ant(4′)-Ia
ND – pK2 (1) TOB, KAN ant(4′)-Ia
8 PVL+ pJ1 (1) – –
8 68 IVc I – pL1 (1) – –
ND 190 IVc I – pK3 (1) TOB, KAN ant(4′)-Ia
22
22 (1) 032 (2) IVh I – pM1 (1) ERY, AZM, SPI, CLI erm(C)
ND – pM3 (1) ERY, AZM erm(C)
ND 1302 IVh I – pM2 (1) – –
1 1 127 IVa III – pO1 (1) ERY, AZM, KAN, STR, TET erm(C), ant(4′)-Ia, tet(K)
398
398 (1)
011 (3) V I
– pN1 (2) STR, TET tet(K), tet(M)
ND – GEN, TOB, KAN, TET, MIN aac(6′)-Ie-aph(2′′), tet(M)
ND – pN2 (1) CLI, GEN, TOB, KAN, STR, TET lnu(A), aac(6′)-Ie-aph(2′′), ant(4′)-Ia, tet(M)
ND: not determined; PVL: Panton–Valentine leukocidin; TSST: toxic shock syndrome toxin.
* ERY: erythromycin, AZM: azithromycin, SPI: spiramycin, CLI: clindamycin, GEN: gentamicin, TOB: tobramycin, AMI: amikacin, KAN: kanamycin, STR: streptomycin, NET: netilmicin, TET: tetracycline, MIN: minocycline, MUP:
mupirocin.
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Amplification of the hypervariable region of the agr locus
showed that agr group II was predominant (88.1%), followed by
agr group I (11.1%) and agr group III (0.8%).
In addition, 79 MRSA isolates were studied by PFGE. A
high genetic variability was found, although some clusters were
observed. Fifteenunrelatedpulsotypeswere identified (namedpul-
sotypes pA–pO). Pulsotypes pA13 (6 isolates), pA22 (3 isolates) and
pC4 (3 isolates) were the most frequent (Table 1).
Sixteen isolateswere further characterizedbyMLSTbeingST125
the predominant (5 isolates) followed by ST8 (4), ST5 (2), ST1, ST22,
ST146, ST228 and ST398.
Distribution in CC was established according to the ST or pre-
sumably assigned according to the spa type. CC5 was the most
prevalent (88.1%) followed by CC8 (5.9%), CC22 (2.5%), CC398 (2.5%)
and CC1 (0.8%).
Discussion
In Spain, MRSA prevalence has remained stable in recent years.
During the course of this study, MRSA prevalence in our hospital
was 30.9%, consistent with other resistance rates found in different
Spanish hospitals.16,17 It has been observed that someMRSA clones
tend to occur more frequently in certain countries or areas18 while
other clones spread worldwide, threatening public health.19 Con-
trolling the infection inhospitals orhealthcare centers could reduce
the overall prevalence of MRSA, for this reason, it is important
to know which clones are circulating in our nosocomial environ-
ment.
Studies conducted in Spain showed that in our country, a
small number of international clones have spread.4 The pre-
dominant Iberian clone before 1996 in Spain was replaced by
CC5/ST228/SCCmecI clone. In our study, five strains belonged to
CC5/ST228/spat041/SCCmecI/agrII profile (one of them possessed
SCCmec type IVc instead of SCCmec type I). These strains showed
high homology in PFGE patterns (pulsotypes pF1 and pF2) and
constant resistance pattern (erm(A)± erm(B) + aac(6′)-Ie-aph(2′′)-
Ia + aph(3′)-IIIa). However, the presence of this clone in Spain has
been steadily declining, being replaced by international EMRSA-16
clone (CC30/ST36/SCCmecII), very common in the UK.4,6 Currently,
this clone has an irregular representation in different institutions
while CC5/ST125/SCCmecIV has become more prevalent.16 High
percentage of our isolates belonged to this CC5/ST125/SCCmecIV.
This high proportion is mainly due to the large number of iso-
lates belonging to spa type t067, although other spa types were
found (Table 1). Approximately one-quarter (22.8%) of isolates
included in spa type t067 were associated with tobramycin and
erythromycin resistance mediated by ant(4′)-Ia and msr(A) genes,
respectively.Moreover,most of the high levelmupirocin resistance
isolates that are circulating in our hospital environment belonged
to CC5/ST125/t067.
In a previous study conducted by our group, we observed that
isolates belonged to CC5/ST125/t067 were predominant in com-
munity areas.12 This finding suggests a great exchange of genetic
lineages from hospital or healthcare services to the community
environment.
Other HA-MRSA clones were detected in our hospi-
tal environment. Three strains included in CC5/ST125/
spat2226/SCCmecIVc/agrII profile belonged to patients admit-
ted to the same nursing home. Isolates belonging to ST5 were
sporadic in our study. Three strainswere included in CC22 (EMRSA-
15), a British clone first detected in 1999 in Spain, always detected
in a very low percentage (<2%).6
The tst gene was detected in one isolate (belong-
ing to CC5/ST5/spat9298/SCCmecI/agrII). This strain seems
to be related with TSST-1 positive ST5 Geraldine clone
(ST5/spat002/SCCmecI/agrII) frequently found in hospital and
community environment in France.20
However, we not only observed HA-MRSA clones circulating by
our hospital or healthcare environment. The presence of typically
community clones (CC8 and CC1) and livestock associated clones
(CC398) was observed. Most of the CA-MRSA strains circulating
in our country were included in USA300 clone or its Latin Amer-
ican variant mainly due to the large population exchanges with
American continent in recent years.24,25 The presence of this clone
was low (five isolates) in our hospital environment. Three isolates,
belonging to Bolivian patients, contained the lukF/lukS-PV genes.
Two of them were recovered from a patient with a breast abscess
and her daughter that showed cellulite in her right inframandibu-
lar area. CC1 includes several strains of CA-MRSA,26 but this CC
also has been detected in animals.27 One of our isolates, obtained
from a Romanian patient with a previous history of animal contact,
belonged to CC1 (ST1/spat127/SCCmecIVa PVL negative).
In our healthcare environment, we observed the presence of
CC-related to animals as CC398. These strains were recovered
from different specimens (sputum, urine and surgical wound) and
belonged to patients with no history of previous contact with
animals (one of them was living in a rural area with a high den-
sity of farms, but we could not confirm animal contact because
the patient died). The relationship between tetracycline resistance
and CC398 strains was already suggested.28 Resistance is mainly Q3
related to tet(M) gene, but not excluded other genes as tet(K) or
tet(L), or even a combination of both, as we have found in one of
our isolates.7 An unusual resistance profile (clindamycin resistance
but erythromycin susceptibility) has been described in ST398 iso-
lates associated with the presence of vga(A) and vga(C) or lnu(A)
genes.29,30 This unusual profile was found in our study encoded by
lnu(A) gene.
In conclusion, in ourhealthcare environment,most of the strains
belong to CC5, where ST125/t067 lineage was the most impor-
tant. This lineage was related to aminoglycoside resistance, and to
a lesser extent, with macrolide resistance. The presence of inter-
national clones as EMRSA-15 (CC22/ST22), European clones as
CC5/ST228, community clones related toCC1orCC8 (mainly carried
by nonnative patients) and livestock associated clones, as CC398,
were observed in a low percentage.
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